Fluid retention is the main reason for the high hospitalization rate among patients with chronic heart failure (CHF). Given the lack of knowledge about fluid intake regulation and its consequences in patients with CHF, current guidelines do not provide …

Background: Ultrasonography is a cost-effective, noninvasive, and expedient imaging modality with numerous clinical applications. Conventional ultrasound uses transducers with frequencies that range from 5 to 12 MHz. However, ultrahigh frequency …

Calcific aortic valve disease (CAVD) is the most common heart valve disorder, yet its mechanism remains poorly understood. Valve interstitial cells (VICs) are the prevalent cells in aortic valve and their osteogenic differentiation may be responsible for …

Ultra-high Frequency Ultrasound Technology Available for Preclinical Research The Vevo imaging platform was the world’s first commercially available ultra-high frequency array-based ultrasound imaging system and has since emerged as the gold standard in …

The Vevo MD opens up new possibilities for medical imaging that have never been seen before with resolution as fine as less than half a grain of sand. Discover the Power of High Resolution Custom-designed and optimized to operate with the Vevo MD are the …

As we continue to develop new products and improve our technology, we sometimes find it necessary to retire products. In order to help you plan ahead and manage your equipment, retired products with their related dates and documentation are outlined …

Hosted at the Hotel Grand Chancellor, Hobart, ANZLAA 2025 will showcase the unparalleled ingenuity of the Australian & New Zealand laboratory animal scientific community. This year, our focus is to showcase diversity in our industry, the importance of …